key: cord-1031027-1y2yiy1p
authors: Zuin, Marco; Rigatelli, Gianluca; Roncon, Loris; Zuliani, Giovanni
title: Left Bundle Branch Block and Mortality in COVID-19 Patients
date: 2021-05-28
journal: Am J Cardiol
DOI: 10.1016/j.amjcard.2021.05.031
sha: 81d471b228ecdb24592ea9c47a2e5a0a5ae8a7f7
doc_id: 1031027
cord_uid: 1y2yiy1p

nan

The prevalence of left bundle branch block (LBBB) in general population is commonly low but its prevalence significant increase in patients with chronic heart failure (HF) [1] . Recent analyses have demonstrated that COVID-19 patients have a significant incidence of acute HF while those with a history of chronic HF are prone to developing acute decompensation. Moreover, these patients frequently develop acute present cardiac injuries which significantly increase the risk of death during the infection [2] . However, the prognostic role of LBBB in patients with SARS-CoV-2 infection has not yet been evaluated. Aim of this manuscript is to perform a brief meta-analysis on the impact of LBBB on short-term mortality risk in COVID-19 patients. The study was performed in accordance with the Preferred Report Items for Systematic Reviews and the presence of LBBB. Conversely, case reports, review articles, editorials/letters, and case series with less than 10 participants, randomized controlled trials and studies including duplicate populations and investigations evaluating the electrocardiographic consequences of specific COVID-19 therapy were excluded. References from the included studies were screened to potentially identify other investigations meeting the inclusion criteria. Ethical approval and informed consent were not required as the study did not directly enrol human subjects. The quality of the included studies was graded using the Newcastle-Ottawa quality assessment scale (NOS). Mortality risk data were pooled using the Mantel-Haenszel random effects models with odds ratio (OR) as the effect measure with 95% CI. Heterogeneity among studies was assessed using Higgins and Thomson I 2 statistic where I 2 values correspond to the following levels of heterogeneity: low (<25%), moderate (25%-75%) and high (>75%). The presence of potential publication bias was verified by visual inspection of the funnel plot.

Due to the low number of the included studies (<10), small-study bias was not examined as our analysis was underpowered to detect such bias. A predefined sensitivity analysis (leave-one-out analysis) was performed removing 1 study at the time, to evaluate the stability of our results. To further appraise the impact of potential baseline confounders, a meta-regression analysis using age, gender, arterial hypertension (HT) and diabetes (DM) as moderator variables was performed. All meta-analyses were conducted using Comprehensive Meta-Analysis software, version 3 (Biostat, USA). Initial search resulted in 1880 articles. After removing duplicates (n=877) and applying our inclusion criteria only 5 studies [3] [4] [5] [6] [7] , enrolling 1580 patients (mean age 65 years old, 989 males) were included in the analysis. The general characteristics of patients enrolled are showed in Table 1 . LBBB was presents in 45 (2.8 %) COVID-19 subjects. On pooled analysis, LBBB was significantly associated with higher risk of death in the short-term period (OR: 3.69, 95% CI: 1.12-12.0, p=0.003, I 2 =51%) ( Figure 1 ). Visual inspection of the relative funnel plot did not reveal significant evidence of publication bias.

Sensitivity analysis yielded consistent results. Meta-regression showed no relationship with age (p=0.88), gender (p=0.62), HT (p=0.50) and DM (p=0.11). The results of present analysis demonstrated a higher mortality risk in COVID-19 patients with LBBB. Unfortunately, we were not able to assess if LBBB was already present before COVID-19 infection or it may be due to a cardiac complication/injury. Moreover, data regarding the prevalence of chronic HF were reported only two investigations not allowing a meta-regression for this variable. The moderate heterogeneity observed may probably be due to the design of the study which probably depends on the participants' inclusion criteria as well as on the study designs and inherited biases.

Further larger clinical studies are needed to confirm our preliminary results.

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: 

The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure

Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis

Association between electrocardiographic features and mortality in COVID-19 patients

Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID-19

Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes

Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection

Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection